FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

12424511000001102: Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44220201000001119 Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
59876001000001112 Spironolactone 10mg/5ml / Chlorothiazide 250mg/5ml oral solution en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Is a Spironolactone + Chlorothiazide true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solution.oral ontology form and route true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Plays role Potassium-sparing diuretic therapeutic role true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has active ingredient Chlorothiazide false Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Is a Product containing chlorothiazide and spironolactone false Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has specific active ingredient Chlorothiazide true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution (Special Order) Is a True Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution 1 ml Is pack of False Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Inferred relationship Existential restriction modifier
Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution 1 ml Has VMP True Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral solution Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start